Orally available prodrug of nucleoside analog inhibitor.
Activity in mouse SARS-CoV and MERS-CoV infection models.
Effective against remdesivir-resistant strains.
Highly important preprint.
biorxiv.org/content/10.110…
High priority to see EIDD-2801, or a combination of EDDD-2801 and remdesivir, in higher mammals.
stm.sciencemag.org/content/11/515…
ncbi.nlm.nih.gov/pmc/articles/P…